Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies

v3.10.0.1
Commitments and Contingencies
9 Months Ended
Sep. 30, 2018
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Note 8 – Commitments and Contingencies
 
Lease
 
The Company leases
14,782
square feet of office and laboratory space located in Austin, Texas. On
April 20, 2018
, the Company entered into an amendment to its existing operating lease which extended the lease term from
May 31, 2018
to
May 21, 2021
. The annual base rent in the first year of the lease extension is $
184,775
and increases by $
7,391
in each succeeding year of the lease extension. In addition, the Company is required to pay its proportionate share of operating costs for the building under this triple net lease.
Future minimum payments under the lease, as amended, are as follows:
 
Year Ended December 31,
 
Amount
 
2018
 
$
46,194
 
2019
 
 
189,086
 
2020
 
 
196,477
 
2021
 
 
83,149
 
 
 
$
514,906
 
 
The Company incurred rent expense of $63,675 and $181,850 for the three and nine months ended September 30, 2018, respectively, and $58,543 and $175,617 for the three and nine months ended September 30, 2017, respectively.
 
License Agreement
 
In 2015, the Company entered into licensing agreements which expire on February 7, 2033. Per the agreements, the Company has an exclusive royalty-free license which enhances its intellectual property portfolio related to semiconductor power switches. The agreements include both fixed and variable payments. The variable payments are a function of the number of associated patent filings pending and patents issued under the agreements. The Company will pay $10,000 for each patent filing pending and $20,000 for each patent issued within 20 days of December 21, 2017 and each subsequent year of the agreement, up to a maximum of $100,000 per year (i.e. five issued patents). At September 30, 2018, two patents associated with the agreements had been issued and the corresponding long-term liability for the estimated present value of future payments under the licensing agreement is $465,181. The Company is accruing interest for future payments related to the issued patent associated with the agreement.